Thalassemia Market Forecast 2026: Revenue Insights According to a newly published market research report by 24LifeSciences, global thalassemia market was valued at USD 3.24 billion in 2024 and is projected to reach USD 5.92 billion by 2031, growing at a compound annual growth rate (CAGR) of 9.2% during the forecast period 20252031. Thalassemia, an inherited blood disorder characterized by abnormal hemoglobin production, leads to excessive destruction of red blood cells and chronic anemia. This condition requires lifelong management through blood transfusions, iron chelation therapy, or potentially curative stem cell transplants. Its prevalence is particularly high in Mediterranean, Middle Eastern, and Southeast Asian populations, driving substantial demand for treatment solutions. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/15711/thalassemia-market